Friday 6 November 2026 Export TARS’s income statement to Excel — free account

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $451.4 million, up 146.7% from fiscal 2024.

Revenue: +63.9%
EPS: −4,699.1%
Free cash flow: −144.1%
Total debt: +0.90%

Quarter to September 2026, against a year earlier

68.81 1.29 +1.91%

Follow TARS

Alert me

Market cap: $3.3B
P/E: 0.0×
Fwd P/E: −10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 9.54
Beneish M: −1.78
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	5	4
ROE Full definition →		(23.39%)	(13.96%)	(13.68%)	(319.84%)
ROA Full definition →		(14.14%)	(8.92%)	(8.40%)	(135.04%)
ROIC Full definition →		0.00%	(96.77%)	0.00%	0.00%
Return on Tangible Assets Full definition →		(16.66%)	(11.73%)	(11.43%)	(293.79%)
Average Days of Receivables Full definition →		70.44	79.95	59.18	54.63
Free Cash Flow per Share Full definition →		(0.53)	(0.73)	1.29	0.70
Free Cash Flow Full definition →		(22.31)	(31.54)	56.00	32.44
Capital Expenditures Full definition →		(9.86)	(15.09)	(18.15)	(17.46)
Other line items
Cash ROIC Full definition →		(2.68%)	(3.89%)	6.44%	6.67%
Accounts Receivable Turnover Full definition →		6.68	5.90	7.65	7.73
Accounts Payable Turnover Full definition →		2.38	0.69	0.69	0.67
Inventory Turnover Full definition →		8.78	9.58	9.88	10.30
Average Days of Payables Full definition →		194.93	252.60	359.59	273.33
Days of Inventory on Hand Full definition →		52.01	47.86	39.21	40.64
Tax Rate Full definition →		0.00	0.05	0.13	0.01
Research and Development Expense of Revenue Full definition →		14.25%	13.51%	14.46%	16.94%
Selling, General and Administrative Expense of Revenue Full definition →		94.67%	89.47%	86.82%	85.87%
Share Based Compensation of Revenue Full definition →		9.24%	8.74%	8.55%	9.79%
Interest Coverage Full definition →		(7.94)	(5.74)	(5.54)	(80.17)
Operating CF/Net income Full definition →		0.19	0.34	(1.60)	(0.07)
Depreciation/Fixed assets Full definition →		(0.26)	(0.15)	(0.05)	0.03
Capex/Depreciation Full definition →		3.21	5.78	16.55	(30.10)
Revenue per Share Full definition →		10.80	12.46	13.97	14.70
Operating CF per Share Full definition →		(0.30)	(0.38)	1.71	1.07
Capex per Share Full definition →		(0.24)	(0.35)	(0.42)	(0.38)
Capex to Sales Full definition →		0.02	0.03	0.03	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly